Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05554133 · ClinicalTrials.gov registry record · NA
Precision Optical Guidance for Oral Biopsy
A NA study of Oral Lesions, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05554133: Recruiting NA study of Oral Lesions, sponsored by M.D. Anderson Cancer Center.
NCT05554133 is a NA study of Oral Lesions that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05554133, a NA study of Oral Lesions, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if a new type of imaging device called the Active Biopsy Guidance System can help doctors to decide when and where to perform invasive biopsies of mouth lesions.
Conditions Studied
Interventions
- DEVICE High Resolution Microendoscope (HRME)
- DEVICE Optical Mapping Scope
- DRUG Proflavine hemisulfate
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT05554133 shows while recruiting
NCT05554133 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Oral Lesions appearing as the primary indexed condition, and to 3 interventions - of which High Resolution Microendoscope (HRME) is the first listed.
NCT05554133 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05554133 about?
NCT05554133 is a clinical study titled "Precision Optical Guidance for Oral Biopsy". To learn if a new type of imaging device called the Active Biopsy Guidance System can help doctors to decide when and where to perform invasive biopsies of mouth lesions.
What is the current status of trial NCT05554133?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-06-15. Estimated completion is 2027-03-31.
What conditions does trial NCT05554133 study?
This clinical trial studies the following conditions: Oral Lesions.
What interventions are being tested in trial NCT05554133?
The interventions under investigation include: High Resolution Microendoscope (HRME) (DEVICE), Optical Mapping Scope (DEVICE), Proflavine hemisulfate (DRUG).
Who is sponsoring clinical trial NCT05554133?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05554133 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05554133's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI